Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Breast tumor microbiome regulates anti-tumor immunity and T cell-associated metabolites.
Journal: Scientific reports
Published: September 27, 2025
Breast tumor microbiome regulates anti-tumor immunity and T cell-associated metabolites.
Journal: bioRxiv : the preprint server for biology
Published: November 18, 2024
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events.
Journal: Clinical genitourinary cancer
Published: July 17, 2023
Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study.
Journal: JTO clinical and research reports
Published: June 27, 2023
Fecal microbiota of adolescent and young adult cancer survivors and metabolic syndrome: an exploratory study.
Journal: Pediatric hematology and oncology
Published: March 10, 2022
Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis.
Journal: Journal for immunotherapy of cancer
Published: August 31, 2021
A Structured Peer Assessment Method with Regular Reinforcement Promotes Longitudinal Self-Perceived Development of Medical Students' Feedback Skills.
Journal: Medical science educator
Published: February 05, 2021
Interplay Between Class II HLA Genotypes and the Microbiome and Immune Phenotypes in Individuals With PTEN Hamartoma Tumor Syndrome.
Journal: JCO precision oncology
Published: September 16, 2020
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma.
Journal: Targeted oncology
Published: September 30, 2018
Order of administration of combination cytokine therapies can decouple toxicity from efficacy in syngeneic mouse tumor models.
Journal: Oncoimmunology
Published: August 08, 2018
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses.
Journal: The Journal of experimental medicine
Published: June 03, 2016
Last Updated: 09/26/2026